Idex Q4 2025: Modest Growth, HST Surge, and Positive FY‑2026 Outlook
Idex Corp’s Q4 2025 earnings grow modestly, driven by its booming Health & Science Tech division, and FY‑2026 guidance signals steady, disciplined growth amid market headwinds.
3 minutes to read









